Inside Nephrology: A Weekly Review
Nefrologia
Cardiorenal Connections: From Pregnancy Risks to Genetic Challenges
This week we explore critical intersections between kidney and cardiovascular health, from pregnancy risks to genetic diagnostic challenges, featuring the latest nephrology research and clinical implications.
Bibliography
1. Hypertension Management in Pregnancy and Postpartum.
Authors: Malha L, August P
Journal: Journal of the American Society of Nephrology : JASN, 2026 Oct 1
PMID: 42545738
DOI: 10.1681/ASN.0000001236
2. The Intersection of Heart Failure with Preserved Ejection Fraction and CKD.
Authors: Krishnan V, Khan SS, Mehta R
Journal: Clinical journal of the American Society of Nephrology : CJASN, 2026 Oct 1
PMID: 41591812
DOI: 10.2215/CJN.0000001013
3. Eplerenone Revisited: A Balanced Reappraisal of Its Role in Hypertension, Heart Failure, and Cardiorenal Disease.
Authors: Bogin V, Weir MR
Journal: Journal of cardiovascular pharmacology, 2026 Oct 1
PMID: 42617196
DOI: 10.1097/FJC.0000000000001875
4. Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition.
Authors: Moedt E, Koshino A, Jongs N, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2026 Oct 1
PMID: 41926219
DOI: 10.1681/ASN.0000001086
5. Diagnosing Mendelian Kidney Disease: Hidden Niches in the (Kidney) Genome.
Authors: Ekici AB, Knaup KX, Schaeffer C, et al.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation, 2026 Oct
PMID: 42497974
DOI: 10.1053/j.ajkd.2026.05.015
6. Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Report from the 34th Acute Disease Quality Initiative (ADQI) Consensus Conference.
Authors: Gupta S, Fenoglio R, Murakami N, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2026 Oct 1
PMID: 42536415
DOI: 10.1681/ASN.0000001232
7. Finerenone in Cardiorenal Disease: A Narrative Review of Molecular Mechanisms, Clinical Evidence, and Emerging Therapeutic Roles.
Authors: Geraci G, Sinatra N, Paternò V, et al.
Journal: Cardiovascular drugs and therapy, 2026 Oct
PMID: 42171960
DOI: 10.1007/s10557-026-07890-7
8. A multi-national study examined the response sustainability to calcineurin inhibitors and long-term kidney survivals in children with genetic podocytopathies.
Authors: Malakasioti G, Iancu D, Au CT, et al.
Journal: Kidney international, 2026 Oct
PMID: 42508611
DOI: 10.1016/j.kint.2026.06.030
9. Renal gluconeogenesis: a key metabolic hub in health and kidney disease.
Authors: Sellami S, Verissimo T, Dalga D, et al.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2026 Sep 30
PMID: 42206809
DOI: 10.1093/ndt/gfag092
10. Risk of Donor-Derived Infections From Organ Donors Colonized or Infected With Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis.
Authors: Paraskevas T, Chatzigrigoriadis C, Kostakis ID, et al.
Journal: Clinical transplantation, 2026 Oct
PMID: 42873093
DOI: 10.1111/ctr.70714
Authors: Malha L, August P
Journal: Journal of the American Society of Nephrology : JASN, 2026 Oct 1
PMID: 42545738
DOI: 10.1681/ASN.0000001236
2. The Intersection of Heart Failure with Preserved Ejection Fraction and CKD.
Authors: Krishnan V, Khan SS, Mehta R
Journal: Clinical journal of the American Society of Nephrology : CJASN, 2026 Oct 1
PMID: 41591812
DOI: 10.2215/CJN.0000001013
3. Eplerenone Revisited: A Balanced Reappraisal of Its Role in Hypertension, Heart Failure, and Cardiorenal Disease.
Authors: Bogin V, Weir MR
Journal: Journal of cardiovascular pharmacology, 2026 Oct 1
PMID: 42617196
DOI: 10.1097/FJC.0000000000001875
4. Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition.
Authors: Moedt E, Koshino A, Jongs N, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2026 Oct 1
PMID: 41926219
DOI: 10.1681/ASN.0000001086
5. Diagnosing Mendelian Kidney Disease: Hidden Niches in the (Kidney) Genome.
Authors: Ekici AB, Knaup KX, Schaeffer C, et al.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation, 2026 Oct
PMID: 42497974
DOI: 10.1053/j.ajkd.2026.05.015
6. Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Report from the 34th Acute Disease Quality Initiative (ADQI) Consensus Conference.
Authors: Gupta S, Fenoglio R, Murakami N, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2026 Oct 1
PMID: 42536415
DOI: 10.1681/ASN.0000001232
7. Finerenone in Cardiorenal Disease: A Narrative Review of Molecular Mechanisms, Clinical Evidence, and Emerging Therapeutic Roles.
Authors: Geraci G, Sinatra N, Paternò V, et al.
Journal: Cardiovascular drugs and therapy, 2026 Oct
PMID: 42171960
DOI: 10.1007/s10557-026-07890-7
8. A multi-national study examined the response sustainability to calcineurin inhibitors and long-term kidney survivals in children with genetic podocytopathies.
Authors: Malakasioti G, Iancu D, Au CT, et al.
Journal: Kidney international, 2026 Oct
PMID: 42508611
DOI: 10.1016/j.kint.2026.06.030
9. Renal gluconeogenesis: a key metabolic hub in health and kidney disease.
Authors: Sellami S, Verissimo T, Dalga D, et al.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2026 Sep 30
PMID: 42206809
DOI: 10.1093/ndt/gfag092
10. Risk of Donor-Derived Infections From Organ Donors Colonized or Infected With Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis.
Authors: Paraskevas T, Chatzigrigoriadis C, Kostakis ID, et al.
Journal: Clinical transplantation, 2026 Oct
PMID: 42873093
DOI: 10.1111/ctr.70714
